Schneider J, Han S, Nabel C
Transl Lung Cancer Res. 2025; 13(12):3692-3717.
PMID: 39830762
PMC: 11736591.
DOI: 10.21037/tlcr-24-662.
Morinaga S, Yamamoto N, Yamauchi K, Hayashi K, Kimura H, Miwa S
Cancer Diagn Progn. 2024; 4(5):544-557.
PMID: 39238629
PMC: 11372698.
DOI: 10.21873/cdp.10362.
Thompson J, Saad M
Methods Mol Biol. 2024; 2806:1-8.
PMID: 38676791
DOI: 10.1007/978-1-0716-3858-3_1.
Stribbling S, Beach C, Ryan A
Pharmacol Ther. 2024; 257:108631.
PMID: 38467308
PMC: 11781865.
DOI: 10.1016/j.pharmthera.2024.108631.
Wang W, Li Y, Lin K, Wang X, Tu Y, Zhuo Z
Animal Model Exp Med. 2023; 6(5):381-398.
PMID: 37679891
PMC: 10614132.
DOI: 10.1002/ame2.12349.
Precise and Facile Endotracheal Lung-tumor-implantation Mouse Model Visualized by GFP Expression.
Aoki Y, Kobayashi K, Varshney N, Kubota Y, Masaki N, Obara K
In Vivo. 2023; 37(4):1477-1481.
PMID: 37369517
PMC: 10347943.
DOI: 10.21873/invivo.13231.
Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma.
Magouliotis D, Lafazanis K, Koutsougianni F, Sakellaridis N, Ioannou M, Zacharoulis D
In Vivo. 2022; 36(3):1114-1119.
PMID: 35478141
PMC: 9087066.
DOI: 10.21873/invivo.12809.
Patient-derived xenograft models in hepatopancreatobiliary cancer.
Pan B, Wei X, Xu X
Cancer Cell Int. 2022; 22(1):41.
PMID: 35090441
PMC: 8796540.
DOI: 10.1186/s12935-022-02454-9.
Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development.
Arnal-Estape A, Foggetti G, Starrett J, Nguyen D, Politi K
Cold Spring Harb Perspect Med. 2021; 11(12).
PMID: 34518338
PMC: 8634791.
DOI: 10.1101/cshperspect.a037820.
Modeling metastasis in mice: a closer look.
Giacobbe A, Abate-Shen C
Trends Cancer. 2021; 7(10):916-929.
PMID: 34303648
PMC: 8906831.
DOI: 10.1016/j.trecan.2021.06.010.
Drug discovery oncology in a mouse: concepts, models and limitations.
Long J, Jankovic M, Maddalo D
Future Sci OA. 2021; 7(8):FSO737.
PMID: 34295539
PMC: 8288236.
DOI: 10.2144/fsoa-2021-0019.
Patient-derived cell line, xenograft and organoid models in lung cancer therapy.
Huo K, DArcangelo E, Tsao M
Transl Lung Cancer Res. 2020; 9(5):2214-2232.
PMID: 33209645
PMC: 7653147.
DOI: 10.21037/tlcr-20-154.
Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Higuchi T, Yamamoto N
Cancer Genomics Proteomics. 2020; 17(4):351-358.
PMID: 32576580
PMC: 7367606.
DOI: 10.21873/cgp.20194.
Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review.
Kawaguchi K, Han Q, Li S, Tan Y, Igarashi K, Murakami T
Cells. 2019; 8(5).
PMID: 31052611
PMC: 6562625.
DOI: 10.3390/cells8050410.
Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
Miyake K, Murata T, Murakami T, Zhao M, Kiyuna T, Kawaguchi K
Arch Gynecol Obstet. 2019; 299(6):1683-1690.
PMID: 30953192
PMC: 11066583.
DOI: 10.1007/s00404-019-05147-3.
Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX).
Malcolm J, Stearns T, Airhart S, Graber J, Bult C
PeerJ. 2019; 7:e6586.
PMID: 30944774
PMC: 6441558.
DOI: 10.7717/peerj.6586.
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.
Kiyuna T, Tome Y, Murakami T, Kawaguchi K, Igarashi K, Miyake K
BMC Cancer. 2018; 18(1):840.
PMID: 30126369
PMC: 6102848.
DOI: 10.1186/s12885-018-4703-0.
Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.
Lwin T, Hoffman R, Bouvet M
J Surg Oncol. 2018; 118(2):253-264.
PMID: 30080930
PMC: 6146062.
DOI: 10.1002/jso.25150.
Tumor-targeting A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations.
Miyake K, Kawaguchi K, Miyake M, Zhao M, Kiyuna T, Igarashi K
Heliyon. 2018; 4(6):e00643.
PMID: 30003151
PMC: 6040627.
DOI: 10.1016/j.heliyon.2018.e00643.
Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
Kawaguchi K, Miyake K, Zhao M, Kiyuna T, Igarashi K, Miyake M
Cell Cycle. 2018; 17(16):2019-2026.
PMID: 29963961
PMC: 6224272.
DOI: 10.1080/15384101.2018.1480223.